STRS OHIO - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$855
-1.4%
18,600
+23.2%
0.00%0.0%
Q2 2023$867
+69.3%
15,100
-17.5%
0.00%
+100.0%
Q4 2022$512
-99.9%
18,300
-33.0%
0.00%
-50.0%
Q3 2022$767,000
+2.1%
27,300
+26.4%
0.00%
+33.3%
Q2 2022$751,000
+295.3%
21,600
+307.5%
0.00%
+200.0%
Q1 2022$190,000
+74.3%
5,300
+12.8%
0.00%
Q4 2021$109,000
+22.5%
4,7000.0%0.00%
Q3 2021$89,000
+8.5%
4,700
+14.6%
0.00%
Q2 2021$82,000
-94.1%
4,100
-94.1%
0.00%
-100.0%
Q3 2019$1,384,000
+88.0%
69,800
+100.0%
0.00%0.0%
Q2 2019$736,000
+12.7%
34,900
+9.1%
0.00%0.0%
Q1 2019$653,000
+10.5%
32,000
+7.7%
0.00%0.0%
Q4 2018$591,000
+24.9%
29,700
+20.7%
0.00%
+50.0%
Q3 2018$473,000
+7.0%
24,600
-15.2%
0.00%0.0%
Q2 2018$442,000
-10.7%
29,000
+9.8%
0.00%0.0%
Q1 2018$495,000
+4400.0%
26,400
+4300.0%
0.00%
Q4 2017$11,000
-97.2%
600
-97.2%
0.00%
-100.0%
Q2 2017$389,000
-31.0%
21,800
-44.0%
0.00%0.0%
Q1 2017$564,000
-21.2%
38,9000.0%0.00%
-33.3%
Q4 2016$716,000
-2.8%
38,9000.0%0.00%0.0%
Q3 2016$737,000
-4.5%
38,900
-18.8%
0.00%0.0%
Q2 2016$772,000
+41.4%
47,900
+5.3%
0.00%
+50.0%
Q1 2016$546,000
-15.6%
45,5000.0%0.00%
-33.3%
Q4 2015$647,000
+21.8%
45,5000.0%0.00%0.0%
Q3 2015$531,000
-33.5%
45,5000.0%0.00%
-25.0%
Q2 2015$799,00045,5000.00%
Q1 2015$0
-100.0%
0
-100.0%
0.00%
Q4 2014$37,000
-50.0%
3,200
-50.0%
0.00%
Q3 2014$74,0006,4000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders